Publications 2022

Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, Brennhovd B, Inderberg EM, Honnashagen TK, Skoge LJ, Solum G, Saeboe-Larssen S, Josefsen D, Olaussen RW, Aamdal S, Skotheim RI, Myklebust TA, Schendel DJ, Lilleby W, Dueland S, Kvalheim G (2022)
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
Prostate, 82 (2), 245-253
DOI 10.1002/pros.24267

Publications 2021

Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S et al. (2021)
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
Lancet Gastroenterol. Hepatol., 6 (11), 933-946
DOI 10.1016/S2468-1253(21)00219-3

Dueland S, Line PD (2021)
Response to the Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases'' Reply
Ann. Surg., 274 (6), E721-E722

Dueland S, Smedman TM, Rosok B, Grut H, Syversveen T, Jorgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl. Int., 34 (11), 2205-2213
DOI 10.1111/tri.13995

Dueland S, Syversveen T, Hagness M, Grut H, Line PD (2021)
Liver transplantation for advanced liver-only colorectal metastases
Br. J. Surg., 108 (12), 1402-1405
DOI 10.1093/bjs/znab196

Dueland S, Yaqub S, Line PD (2021)
Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk Reply
JAMA Surg.
DOI 10.1001/jamasurg.2021.5127

Dueland S, Yaqub S, Syversveen T, Carling U, Hagness M, Brudvik KW, Line PD (2021)
Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases
JAMA Surg., 156 (6), 550-557
DOI 10.1001/jamasurg.2021.0267

Froysnes IS, Andersson Y, Larsen SG, Davidson B, Oien JMT, Julsrud L, Fodstad O, Dueland S, Flatmark K (2021)
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
EJSO, 47 (1), 134-138
DOI 10.1016/j.ejso.2019.04.014

Knuth F, Adde IA, Huynh BN, Groendahl AR, Winter RM, Negard A, Holmedal SH, Meltzer S, Ree AH, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Futsaether CM (2021)
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts
Acta Oncol.
DOI 10.1080/0284186X.2021.2013530

Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD (2021)
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score
Transpl. Int., 34 (9), 1722-1732
DOI 10.1111/tri.13981

Larsen SG, Goscinski MA, Dueland S, Steigen SE, Hofsli E, Torgunrud A, Lund-Iversen M, Dagenborg VJ, Flatmark K, Sorbye H (2021)
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
Br. J. Cancer
DOI 10.1038/s41416-021-01620-6

Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
Metastases in locally advanced rectal cancer undergoing curatively intended treatment
EJSO, 47 (9), 2377-2383
DOI 10.1016/j.ejso.2021.04.023

Meltzer S, Torgunrud A, Abrahamsson H, Solbakken AM, Flatmark K, Dueland S, Bakke KM, Bousquet PA, Negard A, Johansen C, Lyckander LG, Larsen FO, Schou JV, Redalen KR, Ree AH (2021)
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Br. J. Cancer, 125 (2), 240-246
DOI 10.1038/s41416-021-01377-y

Thorgersen EB, Asvall J, Froysnes IS, Schjalm C, Larsen SG, Dueland S, Andersson Y, Fodstad O, Mollnes TE, Flatmark K (2021)
Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann. Surg. Oncol., 28 (9), 5252-5262
DOI 10.1245/s10434-021-10022-0

Publications 2020

Al-Haidari G, Skovlund E, Undseth C, Rekstad BL, Larsen SG, Asli LM, Dueland S, Malinen E, Guren MG (2020)
Re-irradiation for recurrent rectal cancer - a single-center experience
Acta Oncol., 59 (5), 534-540
DOI 10.1080/0284186X.2020.1725111

Andersson Y, Inderberg EM, Kvalheim G, Herud TM, Engebraatena O, Flatmark K, Dueland S, Fodstad O (2020)
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients
Acta Oncol., 59 (4), 404-409
DOI 10.1080/0284186X.2019.1704864

Bains SJ, Abrahamsson H, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Meltzer S, Ree AH (2020)
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Cancer Immunol. Immunother., 69 (3), 355-364
DOI 10.1007/s00262-019-02458-x

Dueland S, Grut H, Syversveen T, Hagness M, Line PD (2020)
Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis
Am. J. Transplant., 20 (2), 530-537
DOI 10.1111/ajt.15682

Dueland S, Line PD (2020)
Liver segment 2+3 living donation in liver transplantation for colorectal liver metastases
Hepatobil. Surg. Nutr., 9 (3), 382-384
DOI 10.21037/hbsn.2019.11.15

Dueland S, Line PD (2020)
Response to the Comment on "Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
Ann. Surg., 271 (5), E124
DOI 10.1097/SLA.0000000000003604

Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bjornbeth BA, Hagness M, Line PD (2020)
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases
Ann. Surg., 271 (2), 212-218
DOI 10.1097/SLA.0000000000003404

Grut H, Stern NM, Dueland S, Labori KJ, Dormagen JB, Schulz A (2020)
Preoperative F-18-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases
Nucl. Med. Commun., 41 (9), 916-923
DOI 10.1097/MNM.0000000000001235

Lanari J, Dueland S, Line PD (2020)
Liver Transplantation for Colorectal Liver Metastasis
Curr. Transplant. Rep., 7 (4), 311-316
DOI 10.1007/s40472-020-00298-8

Line PD, Dueland S (2020)
Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence
J. Hepatol., 73 (6), 1557-1562
DOI 10.1016/j.jhep.2020.08.015

Line PD, Ruffolo LI, Toso C, Dueland S, Nadalin S, Hernandez-Alejandro R (2020)
Liver transplantation for colorectal liver metastases: What do we need to know?
Int. J. Surg., 82 S, 87-92
DOI 10.1016/j.ijsu.2020.03.079

Meltzer S, Bakke KM, Rod KL, Negard A, Flatmark K, Solbakken AM, Kristensen AT, Fuglestad AJ, Kersten C, Dueland S, Seierstad T, Hole KH, Lyckander LG, Larsen FO, Schou JV, Brown DP, Abrahamsson H, Redalen KR, Ree AH (2020)
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
Clin. Transl. Radiat. Oncol., 21, 5-10
DOI 10.1016/j.ctro.2019.11.006

Meltzer S, Bjornetro T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2020)
Circulating Exosomal miR-141-3p and miR375 in Metastatic Progression of Rectal Cancer (vol 12, pg 1038, 2019)
Transl. Oncol., 13 (1), 122-124
DOI 10.1016/j.tranon.2019.09.005

Palmer DH, Valle JW, Ma YT, Faluyi O, Neoptolemos JP, Gjertsen TJ, Iversen B, Eriksen JA, Moller AS, Aksnes AK, Miller R, Dueland S (2020)
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial
Br. J. Cancer, 122 (7), 971-977
DOI 10.1038/s41416-020-0752-7

Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negard A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Florenes VA, Geitvik GA, Lingjaerde OC, Borresen-Dale AL, Russnes HG, Maelandsmo GM, Flatmark K (2020)
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
Acta Oncol., 59 (7), 733-740
DOI 10.1080/0284186X.2020.1742377

Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
BJS Open, 4 (3), 467-477
DOI 10.1002/bjs5.50278

Publications 2019

Abrahamsson H, Porojnicu AC, Lindstrom JC, Dueland S, Flatmark K, Hole KH, Seierstad T, Moan J, Redalen KR, Meltzer S, Ree AH (2019)
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
BMC Cancer, 19, 488
DOI 10.1186/s12885-019-5724-z

Bjornelv GMW, Dueland S, Line PD, Joranger P, Fretland AA, Edwin B, Sorbye H, Aas E (2019)
Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver
Br. J. Surg., 106 (1), 132-141
DOI 10.1002/bjs.10962

Bousquet PA, Meltzer S, Sonstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2019)
Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Caner
Transl. Oncol., 12 (1), 76-83
DOI 10.1016/j.tranon.2018.09.010

Dueland S, Line PD, Hagness M, Foss A, Andersen MH (2019)
Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver
BJS Open, 3 (2), 180-185
DOI 10.1002/bjs5.50116

Lothe IMB, Kleive D, Pomianowska E, Cvancarova M, Kure E, Dueland S, Gladhaug IP, Labori KJ (2019)
Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy
Pancreatology, 19 (2), 316-324
DOI 10.1016/j.pan.2019.01.019

Meltzer S, Bjornetro T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR (2019)
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
Transl. Oncol., 12 (8), 1038-1044
DOI 10.1016/j.tranon.2019.04.014

Smedman TM, Guren TK, Line PD, Dueland S (2019)
Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study
Transpl. Int., 32 (11), 1144-1150
DOI 10.1111/tri.13471

Publications 2018

Boysen AK, Sorensen BS, Lefevre AC, Abrantes R, Johansen JS, Jensen BV, Schou JV, Larsen FO, Nielsen D, Taflin H, Gustayson B, Wettergren Y, Sorensen BS, Ree AH, Dueland S, Pallisgaard N, Spindler KL (2018)
Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer
Clin. Chim. Acta, 487, 107-111
DOI 10.1016/j.cca.2018.09.029

Dueland S, Foss A, Solheim JM, Hagness M, Line PD (2018)
Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma
Br. J. Surg., 105 (6), 736-742
DOI 10.1002/bjs.10769

Grut H, Dueland S, Line PD, Revheim ME (2018)
The prognostic value of F-18-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur. J. Nucl. Med. Mol. Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9

Grut H, Revheim ME, Line PD, Dueland S (2018)
Importance of F-18-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl. Med. Commun., 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843

Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2018)
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br. J. Surg., 105 (3), 295-301
DOI 10.1002/bjs.10651

Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
Br. J. Cancer, 118 (10), 1322-1328
DOI 10.1038/s41416-018-0085-y

Line PD, Hagness M, Dueland S (2018)
The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
Can. J. Gastroenterol. Hepatol., 2018, 8547940
DOI 10.1155/2018/8547940

Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvag HL, Groholt KK, Dueland S, Flatmark K, Larsen SG (2018)
Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
EJSO, 44 (8), 1226-1232
DOI 10.1016/j.ejso.2018.03.029

Smedman TM, Line PD, Guren TK, Dueland S (2018)
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
Acta Oncol., 57 (10), 1414-1418
DOI 10.1080/0284186X.2018.1479069

Publications 2017

Bakke KM, Hole KH, Dueland S, Groholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
Acta Oncol., 56 (6), 813-818
DOI 10.1080/0284186X.2017.1287951

Dueland S, Guren TK, Boberg KM, Reims HM, Grzyb K, Aamdal S, Julsrud L, Line PD (2017)
Acute liver graft rejection after ipilimumab therapy
Ann. Oncol., 28 (10), 2619-2620
DOI 10.1093/annonc/mdx281

Froysnes IS, Andersson Y, Larsen SG, Davidson B, Oien JMT, Olsen KH, Giercksky KE, Julsrud L, Fodstad O, Dueland S, Flatmark K (2017)
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ann. Surg. Oncol., 24 (7), 1916-1922
DOI 10.1245/s10434-017-5814-6

Kalanxhi E, Risberg K, Barua IS, Dueland S, Waagene S, Andersen SN, Pettersen SJ, Lindvall JM, Redalen KR, Flatmark K, Ree AH (2017)
Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
Cancer Res. Treat., 49 (2), 374-386
DOI 10.4143/crt.2016.080

Labori KJ, Guren MG, Brudvik KW, Rosok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjornbeth BA (2017)
Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
Colorectal Dis., 19 (8), 731-738
DOI 10.1111/codi.13622

Labori KJ, Lassen K, Hoem D, Gronbech JE, Soreide JA, Mortensen K, Smaaland R, Sorbye H, Verbeke C, Dueland S (2017)
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial-1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
BMC Surg., 17, 94
DOI 10.1186/s12893-017-0291-1

Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Ostrup O, Hovig E, Nygaard V, Rodland EA, Nakken S, Oien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Florenes VA et al. (2017)
Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
ESMO Open, 2 (2), UNSP e000158
DOI 10.1136/esmoopen-2017-000158

Van Laethem JL, Riess H, Jassem J, Haas M, Martens UM, Weekes C, Peeters M, Ross P, Bridgewater J, Melichar B, Cascinu S, Saramak P, Michl P, Van Brummelen D, Zaniboni A, Schmiegel W, Dueland S, Giurescu M, Garosi VL, Roth K, Schulz A, Seidel H, Rajagopalan P, Teufel M, Childs BH (2017)
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
Target. Oncol., 12 (1), 97-109
DOI 10.1007/s11523-016-0469-y

Publications 2016

Dueland S, Ree AH, Groholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K (2016)
Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
Clin. Oncol., 28 (8), 532-539
DOI 10.1016/j.clon.2016.01.014

Flatmark K, Saelen MG, Hole KH, Abrahamsen TW, Fleten KG, Hektoen HH, Redalen KR, Seierstad T, Dueland S, Ree AH (2016)
Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
Radiother. Oncol., 119 (3), 505-511
DOI 10.1016/j.radonc.2016.02.020

Froysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K (2016)
Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis in Norway: Prognostic Factors and Oncologic Outcome in a National Patient Cohort
J. Surg. Oncol., 114 (2), 222-227
DOI 10.1002/jso.24290

Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH (2016)
Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
BMC Cancer, 16, 536
DOI 10.1186/s12885-016-2601-x

Kyte JA, Aamdal S, Dueland S, Saeboe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G (2016)
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
OncoImmunology, 5 (11), e1232237
DOI 10.1080/2162402X.2016.1232237

Labori KJ, Katz MH, Tzeng CW, Bjornbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP (2016)
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
Acta Oncol., 55 (3), 265-277
DOI 10.3109/0284186X.2015.1068445

Meltzer S, Kalanxhi E, Hektoen HH, Dueland S, Flatmark K, Redalen KR, Ree AH (2016)
Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
Oncotarget, 7 (23), 34907-34917
DOI 10.18632/oncotarget.8995

Redalen KR, Sitter B, Bathen TF, Groholt KK, Hole KH, Dueland S, Flatmark K, Ree AH, Seierstad T (2016)
High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer
Radiother. Oncol., 118 (2), 393-398
DOI 10.1016/j.radonc.2015.11.031

Publications 2015

Andersson Y, Engebraaten O, Juell S, Aamdal S, Brunsvig P, Fodstad O, Dueland S (2015)
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
Br. J. Cancer, 113 (11), 1548-1555
DOI 10.1038/bjc.2015.380

Carling U, Dorenberg EJ, Haugvik SP, Eide NA, Berntzen DT, Edwin B, Dueland S, Rosok R (2015)
Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications
Cardiovasc. Interv. Radiol., 38 (6), 1532-1541
DOI 10.1007/s00270-015-1093-4

Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, Foss A, Tveit KM (2015)
Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?
Ann. Surg., 261 (5), 956-960
DOI 10.1097/SLA.0000000000000786

Dueland S, Hagness M, Line PD, Guren TK, Tveit KM, Foss A (2015)
Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Ann. Surg. Oncol., 22 (7), 2195-2200
DOI 10.1245/s10434-014-4137-0

Hektoen HH, Flatmark K, Andersson Y, Dueland S, Redalen KR, Ree AH (2015)
Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
BMC Cancer, 15, 543
DOI 10.1186/s12885-015-1557-6

Line PD, Hagness M, Berstad AE, Foss A, Dueland S (2015)
A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases The RAPID Concept
Ann. Surg., 262 (1), E5-E9
DOI 10.1097/SLA.0000000000001165

Ree AH, Flatmark K, Saelen MG, Folkvord S, Dueland S, Geisler J, Redalen KR (2015)
Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: Opportunities for signaling-adapted therapies
Crit. Rev. Oncol./Hematol., 95 (1), 114-124
DOI 10.1016/j.critrevonc.2015.01.003

Seierstad T, Hole KH, Groholt KK, Dueland S, Ree AH, Flatmark K, Redalen KR (2015)
MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer
Br. J. Radiol., 88 (1051), 20150097
DOI 10.1259/bjr.20150097

Venugopal B, Awada A, Evans TRJ, Dueland S, Hendlisz A, Rasch W, Hernes K, Hagen S, Aamdal S (2015)
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours
Cancer Chemother. Pharmacol., 76 (4), 785-792
DOI 10.1007/s00280-015-2846-0

Publications 2014

Guren MG, Undseth C, Rekstad BL, Braendengen M, Dueland S, Spindler KLG, Glynne-Jones R, Tveit KM (2014)
Reirradiation of locally recurrent rectal cancer: A systematic review
Radiother. Oncol., 113 (2), 151-157
DOI 10.1016/j.radonc.2014.11.021

Hagness M, Foss A, Egge TS, Dueland S (2014)
Patterns of Recurrence After Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer
Ann. Surg. Oncol., 21 (4), 1323-1329
DOI 10.1245/s10434-013-3449-9

Ree AH, Meltzer S, Flatmark K, Dueland S, Kalanxhi E (2014)
Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks
Int. J. Mol. Sci., 15 (12), 22835-22856
DOI 10.3390/ijms151222835

Ree AH, Saelen MG, Kalanxhi E, Ostensen IHG, Schee K, Roe K, Abrahamsen TW, Dueland S, Flatmark K (2014)
Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy
PLoS One, 9 (2), e89750
DOI 10.1371/journal.pone.0089750

Publications 2013

Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S (2013)
Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer
Ann. Surg., 257 (5), 800-806
DOI 10.1097/SLA.0b013e3182823957

Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2013)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
Ann. Oncol., 24 (1), 152-160
DOI 10.1093/annonc/mds276

Publications 2012

Andersen MH, Dueland S, Hagness M, Vidnes T, Finstad ED, Wahl AK, Foss A (2012)
Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma
Scand. J. Caring Sci., 26 (4), 713-719
DOI 10.1111/j.1471-6712.2012.00984.x

Ree AH, Kristensen AT, Saelen MG, de Wijn R, Edvardsen H, Jovanovic J, Abrahamsen TW, Dueland S, Flatmark K (2012)
Tumor Phosphatidylinositol-3-Kinase Signaling and Development of Metastatic Disease in Locally Advanced Rectal Cancer
PLoS One, 7 (11), e50806
DOI 10.1371/journal.pone.0050806

Sorensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG (2012)
Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei
EJSO, 38 (10), 969-976
DOI 10.1016/j.ejso.2012.06.552

Publications 2011

Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH (2011)
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
Radiat. Oncol., 6, 33
DOI 10.1186/1748-717X-6-33

Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
Clin. Cancer Res., 17 (13), 4568-4580
DOI 10.1158/1078-0432.CCR-11-0184

Suso EMI, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Cancer Immunol. Immunother., 60 (6), 809-818
DOI 10.1007/s00262-011-0991-9

Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE (2011)
Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome
Colorectal Dis., 13 (5), 506-511
DOI 10.1111/j.1463-1318.2010.02256.x

Publications 2010

Folkvord S, Flatmark K, Dueland S, de Wijn R, Groholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
PREDICTION OF RESPONSE TO PREOPERATIVE CHEMORADIOTHERAPY IN RECTAL CANCER BY MULTIPLEX KINASE ACTIVITY PROFILING
Int. J. Radiat. Oncol. Biol. Phys., 78 (2), 555-562
DOI 10.1016/j.ijrobp.2010.04.036

Foss A, Adam R, Dueland S (2010)
Liver transplantation for colorectal liver metastases: revisiting the concept
Transpl. Int., 23 (7), 679-685
DOI 10.1111/j.1432-2277.2010.01097.x

Haugen F, Norheim F, Lian H, Wensaas AJ, Dueland S, Berg O, Funderud A, Skalhegg BS, Raastad T, Drevon CA (2010)
IL-7 is expressed and secreted by human skeletal muscle cells
Am. J. Physiol.-Cell Physiol., 298 (4), C807-C816
DOI 10.1152/ajpcell.00094.2009

Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
Lancet Oncol., 11 (5), 459-464
DOI 10.1016/S1470-2045(10)70058-9

Publications 2009

Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB (2009)
Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., 27 (25), 4116-4123
DOI 10.1200/JCO.2008.20.2515

Dueland S, Aamdal S, Lind MJ, Thomas H, Sandvold ML, Gaullier JM, Rasch W (2009)
Intravenous administration of CP-4055 (ELACYT (TM)) in patients with solid tumours. A phase I study
Acta Oncol., 48 (1), 137-145
DOI 10.1080/02841860802183620

Larsen SG, Wiig JN, Emblemsvaag HL, Groholt KK, Hole KH, Bentsen A, Dueland S, Vetrhus T, Giercksky KE (2009)
Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging
Colorectal Dis., 11 (7), 759-767
DOI 10.1111/j.1463-1318.2008.01649.x

Publications 2008

Bruheim K, Svartberg J, Carlsen E, Dueland S, Haug E, Skovlund E, Tveit KM, Guren MG (2008)
Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH
Int. J. Radiat. Oncol. Biol. Phys., 70 (3), 722-727
DOI 10.1016/j.ijrobp.2007.10.043

Larsen SG, Wiig JN, Dueland S, Giercksky KE (2008)
Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer
EJSO, 34 (4), 410-417
DOI 10.1016/j.ejso.2007.05.012

Wiig JN, Larsen SG, Dueland S, Giercksky KE (2008)
Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence
Colorectal Dis., 10 (1), 48-57
DOI 10.1111/j.1463-1318.2007.01398.x

Publications 2007

Kyte JA, Kvalheim G, Lislerud K, Straten PT, Dueland S, Aamdal S, Gaudernack G (2007)
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
Cancer Immunol. Immunother., 56 (5), 659-675
DOI 10.1007/s00262-006-0222-y

Publications 2006

Guren MG, Tobiassen LB, Trygg KU, Drevon CA, Dueland S (2006)
Dietary intake and nutritional indicators are transiently compromised during radiotherapy for rectal cancer
Eur. J. Clin. Nutr., 60 (1), 113-119
DOI 10.1038/sj.ejcn.1602274

Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
Cancer Gene Ther., 13 (10), 905-918
DOI 10.1038/sj.cgt.7700961

Publications 2005

Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G (2005)
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
Br. J. Cancer, 93 (7), 749-756
DOI 10.1038/sj.bjc.6602761

Sauer T, Guren MG, Noren T, Dueland S (2005)
Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti-EGFR therapy?
Histopathology, 47 (6), 560-564
DOI 10.1111/j.1365-2559.2005.02252.x

Wiig JN, Larsen SG, Dueland S, Giercksky KE (2005)
Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer
J. Surg. Oncol., 92 (1), 70-75
DOI 10.1002/jso.20340

Publications 2004

Guren MG, Schneede J, Tveit KM, Ueland PM, Nexo E, Dueland S (2004)
Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer
Int. J. Radiat. Oncol. Biol. Phys., 60 (3), 807-813
DOI 10.1016/j.ijrobp.2004.04.018

Publications 2003

Dueland S, Guren MG, Olsen DR, Poulsen JP, Tveit KM (2003)
Radiation therapy induced changes in male sex hormone levels in rectal cancer patients
Radiother. Oncol., 68 (3), 249-253
DOI 10.1016/S0167-8140(03)00120-8

Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM (2003)
Epidermal growth factor receptor inhibition induces trichomegaly
Acta Oncol., 42 (4), 345-346
DOI 10.1080/02841860310006038

Tonstad S, Hjermann I, Dueland S (2003)
Klinisk smågruppeundervisning: for studenter i ernæring : 3. semester
Unipub kompendier, [Oslo], 13 s.
BIBSYS 03143004x

Publications 2001

Dueland S, Wist E, Loberg M, Iversen JR (2001)
Cutaneous relapse of testicular embryonic carcinoma
J. Urol., 165 (3), 909
DOI 10.1016/S0022-5347(05)66565-2

Guren MG, Wiig JN, Dueland S, Tveit KM, Fossa SD, Waehre H, Giercksky KE (2001)
Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer
Eur. J. Surg. Oncol., 27 (7), 645-651

Publications 1998

Dueland S, Stenwig AE, Heilo A, Hoie J, Ous S, Fossa SD (1998)
Treatment and outcome of patients with extragonadal germ cell tumours - the Norwegian Radium Hospital's experience 1979-94
Br. J. Cancer, 77 (2), 329-335
DOI 10.1038/bjc.1998.51

Publications 1991

DUELAND S, MYHRE K, DUELAND N, SAUGSTAD OD (1991)
INCREASED PLASMA HYPOXANTHINE VALUES IN HUMANS DURING EXPOSURE TO SIMULATED ALTITUDE OF 7,620 METERS (25,000 FEET)
Aviat. Space Environ. Med., 62 (11), 1044-1049

DUELAND S, NENSETER MS, DREVON CA (1991)
UPTAKE AND DEGRADATION OF FILAMENTOUS ACTIN AND VITAMIN-D-BINDING PROTEIN IN THE RAT
Biochem. J., 274, 237-241
DOI 10.1042/bj2740237

Publications 1990

DUELAND S, BLOMHOFF R, PEDERSEN JI (1990)
UPTAKE AND DEGRADATION OF VITAMIN-D BINDING-PROTEIN AND VITAMIN-D BINDING-PROTEIN ACTIN COMPLEX INVIVO IN THE RAT
Biochem. J., 267 (3), 721-725
DOI 10.1042/bj2670721

Publications 1985

ALBRECHTSEN D, HELGERUD P, RUGSTAD HE, DUELAND S (1985)
VERY HIGH-CONCENTRATION IN INTESTINAL LYMPH AFTER ORAL, BUT NOT AFTER INTRAVENOUS, CYCLOSPORINE IN THE RAT
Transplantation, 40 (2), 220-222
DOI 10.1097/00007890-198508000-00025

Dueland S (1985)
Absorption and transport of vitamin D3 and 25-hydroxyvitamin D3 in the rat
Institute for Nutrition Research, School of Medicine and Department of Pharmacology, Institute of Pharmacy, Universityof Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 862069319

DUELAND S, BOUILLON R, VANBAELEN H, PEDERSEN JI, HELGERUD P, DREVON CA (1985)
BINDING-PROTEIN FOR VITAMIN-D AND ITS METABOLITES IN RAT MESENTERIC LYMPH
Am. J. Physiol., 249 (1), E1-E5
DOI 10.1152/ajpendo.1985.249.1.E1

Publications 1984

BLOMHOFF R, HELGERUD P, DUELAND S, BERG T, PEDERSEN JI, NORUM KR, DREVON CA (1984)
LYMPHATIC ABSORPTION AND TRANSPORT OF RETINOL AND VITAMIN-D-3 FROM RAT INTESTINE - EVIDENCE FOR DIFFERENT PATHWAYS
BIOCHIM BIOPHYS ACTA, 772 (2), 109-116
DOI 10.1016/0005-2736(84)90033-6

Publications 1983

DUELAND S, HELGERUD P, PEDERSEN JI, BERG T, DREVON CA (1983)
PLASMA-CLEARANCE, TRANSFER, AND DISTRIBUTION OF VITAMIN-D3 FROM INTESTINAL LYMPH
Am. J. Physiol., 245 (4), E326-E331
DOI 10.1152/ajpendo.1983.245.4.E326

DUELAND S, PEDERSEN JI, HELGERUD P, DREVON CA (1983)
ABSORPTION, DISTRIBUTION, AND TRANSPORT OF VITAMIN-D3 AND 25-HYDROXYVITAMIN-D3 IN THE RAT
Am. J. Physiol., 245 (5), E463-E467
DOI 10.1152/ajpendo.1983.245.5.E463

Publications 1982

DAVIS RA, HELGERUD P, DUELAND S, DREVON CA (1982)
EVIDENCE THAT REVERSE CHOLESTEROL TRANSPORT OCCURS INVIVO AND REQUIRES LECITHIN-CHOLESTEROL ACYLTRANSFERASE
BIOCHIM BIOPHYS ACTA, 689 (2), 410-414
DOI 10.1016/0005-2736(82)90276-0

DUELAND S, PEDERSEN JI, DREVON CA, BJORKHEM I (1982)
26-HYDROXYLATION OF 5-BETA-CHOLESTANE-3-ALPHA,7-ALPHA,12-ALPHA-TRIOL BY ISOLATED NON-PARENCHYMAL CELLS AND HEPATOCYTES FROM RAT-LIVER
J. Lipid Res., 23 (9), 1321-1327

DUELAND S, PEDERSEN JI, HELGERUD P, DREVON CA (1982)
TRANSPORT OF VITAMIN-D3 FROM RAT INTESTINE - EVIDENCE FOR TRANSFER OF VITAMIN-D3 FROM CHYLOMICRONS TO ALPHA-GLOBULINS
J. Biol. Chem., 257 (1), 146-150

HANSEN CE, DUELAND S, DREVON CA, STORMER FC (1982)
METABOLISM OF OCHRATOXIN-A BY PRIMARY CULTURES OF RAT HEPATOCYTES
Appl. Environ. Microbiol., 43 (6), 1267-1271
DOI 10.1128/AEM.43.6.1267-1271.1982

Publications 1981

DUELAND S, HOLMBERG I, BERG T, PEDERSEN JI (1981)
UPTAKE AND 25-HYDROXYLATION OF VITAMIN-D3 BY ISOLATED RAT-LIVER CELLS
J. Biol. Chem., 256 (20), 430-434

Hansen CE, Dueland S, Drevon CA (1981)
Metabolism of ochratoxin A by primary cultures of rat hepatocytes: Vedlegg til C.E Hansens hovedoppgave
In Hydroksylering av ochratoxin A i lever-mikrosomer og hepatocytter i kultur, C.E Hansen, Oslo, 3, 22 s.
BIBSYS 96136873x